DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 088737
NDA 088737 describes THIORIDAZINE HYDROCHLORIDE, which is a drug marketed by Actavis Mid Atlantic, Alpharma Us Pharms, Ani Pharms Inc, Hi Tech Pharma, Pharm Assoc, Sandoz, Wockhardt, Fosun Pharma, Mutual Pharm, Mylan, Par Pharm, Roxane, Sun Pharm Industries, Superpharm, Watson Labs, Watson Labs Teva, and West Ward, and is included in seventy-nine NDAs. It is available from four suppliers. Additional details are available on the THIORIDAZINE HYDROCHLORIDE profile page.
The generic ingredient in THIORIDAZINE HYDROCHLORIDE is thioridazine hydrochloride. There are eighteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the thioridazine hydrochloride profile page.
The generic ingredient in THIORIDAZINE HYDROCHLORIDE is thioridazine hydrochloride. There are eighteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the thioridazine hydrochloride profile page.
Summary for 088737
| Tradename: | THIORIDAZINE HYDROCHLORIDE |
| Applicant: | Sun Pharm Industries |
| Ingredient: | thioridazine hydrochloride |
| Patents: | 0 |
| Therapeutic Class: | Antipsychotics |
| Formulation / Manufacturing: | see details |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 150MG | ||||
| Approval Date: | Sep 26, 1984 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
